Defining the oncogenic potential and therapeutic dependencies of PDAC-associated KRAS variants Grant

Overview

date/time interval

November 25, 2024 - October 31, 2029

awarded by

National Cancer Institute

administered by

Surgery

sponsor award ID

1 R01 CA290616-01A1

Affiliation

contributor

Chandwani, Rohit Principal Investigator 2024 - 2029
Dow, Lukas Edward Co-Principal Investigator 2024 - 2029
Hissong, Erika Co-Investigator 2024 - 2029